OUR SERVICES

Molecular Genetics

Molecular Diagnostics (Haematology and Solid Tumour)

Austin Pathology Molecular Diagnostics laboratory offers services including massively parallel sequencing, fragment analysis, droplet digital PCR and quantitative RT-PCR for haematology and solid tumour testing in a NATA accredited setting. Knowledge about the human genome and opportunities to use medical genetics and genomics in medical practice has expanded over the last couple of decades. Diagnosis, classification, therapeutics and disease monitoring of haematological and solid organ diseases rely on integration of morphological, immunophenotypic and genomic information.

Austin Pathology provides patient focused service with a high-level of clinical and scientific guidance that is supported by Haematologists, Anatomical Pathologists and Molecular Scientists.

Contact Details
General Enquiries

Click here to download the Molecular Haematology Request Form

Please check government eligibility criteria on the MBS Online Website for Medicare funded tests with the relevant MBS item numbers.

Clinical Indication: Suspected myeloid malignancy

Gene List: ASXL1, BRAF, CALR, CBL, CEBPA, CSF3R, CXCR4, DNMT3A, DDX41, ETNK1, EZH2, FBXW7, FLT3*, GATA1, GATA2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, MYD88, NOTCH1, NPM1, NRAS, PPM1D, PTEN, RHOA, RUNX1, SETBP1, SF3B1, SRSF2, STAT3, STAT5B, STAT6, TET2, TP53, U2AF1, WT1.

*FLT3-ITD is reported using fragment analysis.

 

Method: Next Generation Sequencing (NGS) 

 

MBS Item No. 73447

Please contact us for pricing for Non-Medicare eligible patients.

 

Test Information and Sample Requirements:

Blood

Bone Marrow

DNA 

 

Expected Turnaround Time: 3-4 Weeks

Click here to download the Molecular Solid Tumour Request Form

Please check government eligibility criteria on the MBS Online Website for Medicare funded tests with the relevant MBS item numbers.